---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-011080"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2024-03-25T23:59:59+00:00"
generated_at: "2026-06-04T08:45:23.352865+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Indaptus to present Decoy10 data at AACR showing immune activation

## Summary
- CSO Michael Newman to present Decoy10 poster at AACR 2024 in San Diego on April 10.
- Data confirm mechanism of action: Decoy bacteria activate M1 macrophages, NK, dendritic, Th1 CD4, and CD8 T cells.
- Abstract published in AACR journal Cancer Research to support the findings.

## SEC filing metadata
- accession: 0001493152-24-011080
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2024-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315224011080/0001493152-24-011080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315224011080/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-011080
- JSON: https://secwatch.observer/filing/0001493152-24-011080.json
- Plain text: https://secwatch.observer/filing/0001493152-24-011080.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.